Multimeric Biotherapeutics, Inc.

MegaLigand image

Intellectual Property

Multimeric has exclusive licenses for all therapeutic uses of the following issued and pending patent families in all territories worldwide, including the U.S., Europe, Canada,China, Japan, Korea, Brazil, South Africa, Israel, and Australia:

Issued Patents

Multimeric Fusion Proteins of the TNF Superfamily Ligands

US 7,300,774, November 27, 2007 (1.8 MB PDF)

Nucleic Acids Encoding Multimeric Proteins of TNF Superfamily Ligands

US 7,332,298, February 19, 2008, Division of US 7,300,774 with nucleic acid claims (1.8 MB PDF)

Multimeric Forms of TNF Superfamily Ligands

EP1235853B1, July 22, 2009 (1.7 MB PDF)

Di- or Oligomer of a Dimer, Trimer, Quatromer or Pentamer of Recombinant Fusion Proteins

EP1246925B1, May 28, 2008 (0.7 MB PDF) [exclusive of MegaFasL, APO010]

Patent Applications
Immunostimulatory Combinations for Vaccine Adjuvants

US 2009/0081157 A1, published March 26, 2009 (2.5 MB PDF)

Composition Comprised of Antigen Linked to a TNF Superfamily Ligand

WO 2014/145355 A1, published September 18, 2014 (3.1 MB PDF)